Trials / Unknown
UnknownNCT05745896
A Telemedicine Prenatal Care Model on Low Risk Pregnants: The m@Mae-e Study
A Telemedicine Prenatal Care Model on Low Risk Pregnants: An Effectiveness Randomized Clinical Trial (The m@Mae-e Study)
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Talita Colombo · Academic / Other
- Sex
- Female
- Age
- 18 Years – 34 Years
- Healthy volunteers
- Accepted
Summary
This study will compare the effectiveness of a prenatal care supported by telemedicine against usual care in low-risk pregnant women. The investigators will follow-up women in a gestational age of 6 weeks up to 41 weeks, and 6 postpartum weeks. The primary outcome is the anxiety level estimated by the General Anxiety Scale 7 scale (GAD-7 Scale).
Detailed description
This is a pragmatic, effectiveness, superiority randomized clinical trial (RCT), in which low risk pregnants will be randomized to a prenatal care program supported by telemedicine or usual care in an allocation ratio of 1:1. The follow-up period will last 41 weeks from inception (i.e., 6 to 13 weeks of gestational age) to pregnancy and a extension period of 6 weeks in the postpartum stage. The investigators settled anxiety levels estimated by the General Anxiety Scale 7 scale as primary outcome in a between-groups mean difference after the 3rd trimester. Secondary outcomes include: delivery mode, obstetric events and fetal and neonatal variables of epidemiological surveillance interest (birth weight, birth height and APGAR score; maternal, fetal and neonatal fatal and non-fatal events). The interventions will occur as follows: for usual care, all appointments (at least 9 outpatient clinic visits) will be carried forward in person by a senior obstetrician. Patients randomized for the telemedicine supported group should will attend at least 6 in person and 3 online appointments. All pregnant women will receive the standardized care throughout the study. The sample size calculation was based on the primary outcome, assuming between-groups mean difference of 4 points plus a 4-points standard deviation, at a statistical of 80% and a two-tailed 5% type I error. Further, a 15% of addition was done for potential impairments during the follow-up, ending in 30 patients per group. The m@mae-e study's setting will be the at Santa Casa de Misericórdia, (Porto Alegre, Brazil).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Telemedicine appointment | Three online appointments for pregnancy monitoring at prenatal care. |
| OTHER | Face-to-face appointment | Six to nine face-to-face appointments for pregnancy monitoring at prenatal care. |
Timeline
- Start date
- 2023-07-01
- Primary completion
- 2025-12-31
- Completion
- 2026-03-01
- First posted
- 2023-02-27
- Last updated
- 2023-02-27
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT05745896. Inclusion in this directory is not an endorsement.